Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus

Tuberculosis

Volumn 93, Issue SUPPL., 2013, Pages

  Restrepo, Blanca I ^a   Schlesinger, Larry S ^b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Adaptive immunity; Diabetes; Hyperglycemia; Innate immunity; Review; Tuberculosis

Indexed keywords

ADAPTIVE IMMUNITY; ADVERSE OUTCOME; ARTICLE; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EPIDEMIOLOGICAL DATA; HISTORY; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE DYSREGULATION; IMMUNE SYSTEM; IN VITRO STUDY; INNATE IMMUNITY; MEDICAL HISTORY; MYCOBACTERIUM TUBERCULOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TUBERCULOSIS;

ADAPTIVE IMMUNITY; DIABETES; HYPERGLYCEMIA; INNATE IMMUNITY; REVIEW; TUBERCULOSIS;

ADAPTIVE IMMUNITY; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; DIABETES MELLITUS, TYPE 2; DISEASE SUSCEPTIBILITY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; MALE; MYCOBACTERIUM TUBERCULOSIS; RISK FACTORS; TUBERCULOSIS;

EID: 84891598448     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/S1472-9792(13)70004-0     Document Type: Article

References (60)

1. World Health Organization Global tuberculosis report 2012 Available at: http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502-eng.pdf 2012
2. Morton, R. 1694. Phthisiologia, Or a Treatise of Consumptions. London, England. -360 pp.
3. AL Banyai Diabetes and pulmonary tuberculosis Am Rev Tuberc 24 1931 650 667
4. PN Oscarsson, H Silwer Incidence of pulmonary tuberculosis among diabetics Acta Med Scand 335 1958 23 48
5. HF Root The association of diabetes and tuberculosis N Engl J Med 210 1934 1 13
6. AM Prentice The emerging epidemic of obesity in developing countries Int J Epidemiol 35 2006 93 99
7. International Diabetes Federation Diabetes Atlas Available at: http://www.diabetesatlas.org/ 2009
8. C Dye Global epidemiology of tuberculosis Lancet 367 2006 938 940
9. CY Jeon, AD Harries, MA Baker, JE Hart, A Kapur, K Lonnroth et al. Bidirectional screening for tuberculosis and diabetes: a systematic review Trop Med Int Health 15 2010 1300 1314
10. SE Ottmani, MB Murray, CY Jeon, MA Baker, A Kapur, K Lonnroth et al. Consultation meeting on tuberculosis and diabetes mellitus: meeting summary and recommendations Int J Tuberc Lung Dis 14 2010 1513 1517
11. CY Jeon, MB Murray Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies PLoS Med 5 2008 1091 1101
12. CC Leung, TH Lam, WM Chan, WW Yew, KS Ho, GM Leung et al. Diabetic control and risk of tuberculosis: a cohort study Am J Epidemiol 167 2008 1486 1494
13. CR Stevenson, NG Forouhi, G Roglic, BG Williams, JA Lauer, C Dye et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence BMC Public Health 7 2007 234
14. A Ponce-De-Leon, MdL Garcia-Garcia, MC Garcia-Sancho, FJ Gomez-Perez, JL Valdespino-Gomez, G Olaiz-Fernandez et al. Tuberculosis and diabetes in southern Mexico Diabetes Care 27 2004 1584 1590
15. B Restrepo, A Camerlin, M Rahbar, M Restrepo, I Zarate, R Wing et al. Cross-sectional assessment reveals high diabetes prevalence among newly-diagnosed tuberculosis patients Bull World Health Organ 89 2011 352 359
16. EL Corbett, CJ Watt, N Walker, D Maher, BG Williams, MC Raviglione et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic Arch Intern Med 163 2003 1009 1021
17. A Pablos-Mendez, J Blustein, CA Knirsch The role of diabetes mellitus in the higher prevalence of tuberculosis among Hispanics Am J Public Health 87 1997 574 579
18. MA Baker, AD Harries, CY Jeon, JE Hart, A Kapur, K Lonnroth et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review BMC Med 9 2011 81
19. RJ Al-Attiyah, AS Mustafa Mycobacterial antigen-induced T helper type 1 (Th1) and Th2 reactivity of peripheral blood mononuclear cells from diabetic and non-diabetic tuberculosis patients and Mycobacterium bovis bacilli Calmette-Guerin (BCG)-vaccinated healthy subjects Clin Exp Immunol 158 2009 64 73
20. NP Kumar, R Sridhar, VV Banurekha, MS Jawahar, TB Nutman, S Babu Expansion of pathogen-specific T-helper 1 and T-helper 17 cells in pulmonary tuberculosis with coincident type 2 diabetes mellitus J Infect Dis 208 2013 739 748
21. B Restrepo, S Fisher-Hoch, P Pino, A Salinas, MH Rahbar, F Mora et al. Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells Clin Infect Dis 47 2008 634 641
22. M Walsh, A Camerlin, R Miles, P Pino, P Martinez, F Mora-Guzman et al. Sensitivity of Interferon-gamma release assays is not compromised in tuberculosis patients with diabetes Int J Tuberc Lung Dis 15 2010 179 184
23. B Reis-Santos, R Locatelli, BL Horta, E Faerstein, MN Sanchez, LW Riley et al. Socio-Demographic and Clinical Differences in Subjects with Tuberculosis with and without Diabetes Mellitus in Brazil - A Multivariate Analysis PLoS ONE 8 2013 e62604
24. BI Restrepo, SP Fisher-Hoch, JG Crespo, E Whitney, A Perez, B Smith et al. Type 2 diabetes and tuberculosis in a dynamic bi-national border population Epidemiol Infect 135 2007 483 491
25. JN Lin, CH Lai, YH Chen, SS Lee, SS Tsai, CK Huang et al. Risk factors for extrapulmonary tuberculosis compared to pulmonary tuberculosis Int J Tuberc Lung Dis 13 2009 620 625
26. F Bacakoglu, OO Basoglu, G Cok, A Sayiner, M Ates Pulmonary tuberculosis in patients with diabetes mellitus Respiration 68 2001 595 600
27. B Restrepo, S Fisher-Hoch, B Smith, S Jeon, MH Rahbar, J McCormick Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes Am J Trop Med Hyg 79 2008 541 544
28. M Guler, E Unsal, B Dursun, O Aydln, N Capan Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis Int J Clin Pract 61 2007 231 235
29. American Diabetes Association Standards of Medical Care in Diabetes-2010 Diabetes Care 33 2010 S11 S61
30. D Nandy, R Janardhanan, D Mukhopadhyay, A Basu Effect of hyperglycemia on human monocyte activation J Investig Med 59 2011 661 667
31. PS Hair, CG Echague, RD Rohn, NK Krishna, JO Nyalwidhe, KM Cunnion Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus J Transl Med 10 2012 35
32. R Dolhofer, EA Siess, OH Wieland Nonenzymatic glycation of immunoglobulins leads to an impairment of immunoreactivity Biol Chem Hoppe Seyler 366 1985 361 366
33. MA Niemann, AS Bhown, EJ Miller The principal site of glycation of human complement factor B Biochem J 274 Pt 2 1991 473 480
34. M Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
35. A Lapolla, D Fedele, R Seraglia, S Catinella, P Traldi Matrix-assisted laser desorption/ionization capabilities in the study of non-enzymatic protein glycation Rapid Commun Mass Spectrom 8 1994 645 652
36. DI Gomez, M Twahirwa, LS Schlesinger, BI Restrepo Reduced Mycobacterium tuberculosis association with monocytes from diabetes patients that have poor glucose control Tuberculosis (Edinb) 93 2013 192 197
37. K Tsukaguchi, H Okamura, K Matsuzawa, M Tamura, R Miyazaki, S Tamaki et al. [Longitudinal assessment of IFN-gamma production in patients with pulmonary tuberculosis complicated with diabetes mellitus] Kekkaku 77 2002 409 413
38. KS Tan, KO Lee, KC Low, AM Gamage, Y Liu, GY Tan et al. Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria J Clin Invest 122 2012 2289 2300
39. S Grzybowski, GD Barnett, K Styblo Contacts of cases of active pulmonary tuberculosis Bull Int Union Tuberc 50 1975 90 106
40. L Richeldi, K Ewer, M Losi, BM Bergamini, P Roversi, J Deeks et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure Am J Respir Crit Care Med 170 2004 288 295
41. E Guirado, LS Schlesinger Modeling the Mycobacterium tuberculosis Granuloma - the Critical Battlefield in Host Immunity and Disease Front Immunol 4 2013 98
42. JD Ernst The immunological life cycle of tuberculosis Nat Rev Immunol 12 2012 581 591
43. LS Schlesinger Entry of Mycobacterium tuberculosis into mononuclear phagocytes Curr Top Microbiol Immunol 215 1996 71 96
44. SS Stew, PJ Martinez, F Mora-Guzman, LS Schlesinger, BI Restrepo Differential expression of monocyte surface markers among TB patients with diabetes co-morbidity Tuberculosis (Edinb) 93 Suppl 1 2013 S78 S82
45. J Panee Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes Cytokine 60 2012 1 12
46. T Vallerskog, GW Martens, H Kornfeld Diabetic mice display a delayed adaptive immune response to Mycobacterium tuberculosis J Immunol 184 2010 6275 6282
47. MF Molina, HQ Qu, AR Rentfro, S Nair, Y Lu, CL Hanis et al. Decreased expression of ATP6V1H in type 2 diabetes: a pilot report on the diabetes risk study in Mexican Americans Biochem Biophys Res Commun 412 2011 728 731
48. HQ Qu, AR Rentfro, Y Lu, S Nair, CL Hanis, JB McCormick et al. Host susceptibility to tuberculosis: insights from a longitudinal study of gene expression in diabetes Int J Tuberc Lung Dis 16 2012 370 372
49. I Gonzalez-Curiel, J Castaneda-Delgado, N Lopez-Lopez, Z Araujo, R Hernandez-Pando, B Gandara-Jasso et al. Differential expression of antimicrobial peptides in active and latent tuberculosis and its relationship with diabetes mellitus Hum Immunol 72 2011 656 662
50. M Fabri, S Stenger, DM Shin, JM Yuk, PT Liu, S Realegeno et al. Vitamin D is required for IFN-gamma-mediated antimicrobial activity of human macrophages Sci Transl Med 3 2011 104ra102
51. PT Liu, RL Modlin Human macrophage host defense against Mycobacterium tuberculosis Curr Opin Immunol 20 2008 371 376
52. AR Martineau, S Nhamoyebonde, T Oni, MX Rangaka, S Marais, N Bangani et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa Proc Natl Acad Sci U S A 108 2011 19013 19017
53. C Mathieu, C Gysemans, A Giulietti, R Bouillon Vitamin D and diabetes Diabetologia 48 2005 1247 1257
54. X Palomer, JM Gonzalez-Clemente, F Blanco-Vaca, D Mauricio Role of vitamin D in the pathogenesis of type 2 diabetes mellitus Diabetes Obes Metab 10 2008 185 197
55. Q Sun, Q Zhang, H Xiao, H Cui, B Su Significance of the frequency of CD4+CD25+C Respirology 17 2012 876 882
56. JE Stalenhoef, B Alisjahbana, EJ Nelwan, V van d, TH Ottenhoff, JW van der Meer et al. The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus Eur J Clin Microbiol Infect Dis 27 2008 97 103
57. K Tsukaguchi, H Okamura, M Ikuno, A Kobayashi, A Fukuoka, H Takenaka et al. [The relation between diabetes mellitus and IFN-gamma, IL-12 and IL-10 productions by CD4+ alpha beta T cells and monocytes in patients with pulmonary tuberculosis] Kekkaku 72 1997 617 622
58. GW Martens, MC Arikan, J Lee, F Ren, D Greiner, H Kornfeld Tuberculosis Susceptibility of Diabetic Mice Am J Respir Cell Mol Biol 37 2007 518 524
59. S Yamashiro, K Kawakami, K Uezu, T Kinjo, K Miyagi, K Nakamura et al. Lower expression of Th1-related cytokines and inducible nitric oxide synthase in mice with streptozotocin-induced diabetes mellitus infected with Mycobacterium tuberculosis Clin Exp Immunol 139 2005 57 64
60. JL Flynn, J Chan Immunology of tuberculosis Annu Rev Immunol 19 2001 93 129